ZNF582 Activators
ZNF582 utilize a variety of intracellular signaling pathways to modulate the protein's function. Forskolin, by raising intracellular cAMP levels, directly stimulates adenylyl cyclase, which in turn activates protein kinase A (PKA). PKA phosphorylates transcription factors, augmenting the transcription of genes that encode proteins interacting with ZNF582, thus enhancing its activation. Similarly, isoproterenol, a beta-adrenergic agonist, elevates cAMP levels, leading to the activation of PKA and subsequent phosphorylation of proteins that regulate ZNF582. Dibutyryl-cAMP and 8-Bromo-cAMP, both cell-permeable cAMP analogs, also activate PKA, which then targets proteins that interact with ZNF582, resulting in its activation.
Other chemicals act through different mechanisms. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which phosphorylates various substrates that may include proteins involved in ZNF582 regulation. Epidermal Growth Factor (EGF) binds to its receptor, initiating a cascade that leads to the activation of the MAPK/ERK pathway, which can phosphorylate proteins that enhance ZNF582 function. Ionomycin increases calcium levels within cells, activating calcineurin, which can dephosphorylate and activate transcription factors influencing ZNF582. Retinoic acid interacts with nuclear receptors to regulate gene transcription, impacting proteins that modulate ZNF582 activity. Sodium fluoride inhibits GTPase, enhancing G protein-coupled receptor signaling and kinase activation, which can lead to ZNF582 phosphorylation. Lithium chloride inhibits glycogen synthase kinase-3, potentially leading to the activation of proteins that regulate ZNF582. Lastly, anisomycin activates stress-activated protein kinases like JNK, which phosphorylates transcription factors that can enhance ZNF582 activity, and Bay K8644, as an L-type calcium channel agonist, increases intracellular calcium to activate kinases that may phosphorylate and activate ZNF582.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide array of substrates that could include factors directly interacting with ZNF582, leading to its functional activation through post-translational modifications. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcineurin. Activated calcineurin dephosphorylates nuclear factor of activated T-cells (NFAT), which can then enhance the transcription of genes including those that may encode proteins interacting with ZNF582, leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, similar to forskolin, thereby activating PKA. PKA can then phosphorylate proteins that are involved in the regulation of ZNF582, leading to its activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates retinoic acid receptors (RARs) which can dimerize with retinoid X receptors (RXRs) and bind to retinoic acid response elements (RARE) in the DNA, potentially enhancing the transcription of target genes whose products could be involved in the functional activation of ZNF582. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can lead to the phosphorylation of proteins that may be associated with the functional activation of ZNF582. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride activates G proteins by inhibiting GTPase, leading to sustained G protein-coupled receptor signaling. This can enhance signaling pathways that lead to the activation of kinases, which may phosphorylate and activate ZNF582. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), which can lead to the stabilization and activation of β-catenin. Activated β-catenin may enter the nucleus and influence the transcription of genes whose products could be involved in the functional activation of ZNF582. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs), such as JNK. JNK activation leads to the phosphorylation of transcription factors that could enhance the activity of ZNF582 through protein-protein interactions and functional cooperativity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is another cell-permeable cAMP analog that activates PKA. PKA can phosphorylate regulatory proteins that might interact with ZNF582, leading to its functional activation. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as an L-type calcium channel agonist, increasing calcium influx. The resulting increase in intracellular calcium can activate calmodulin-dependent kinases (CaMK), which could phosphorylate proteins that interact with and activate ZNF582. | ||||||